Best for: 40+ patients, slower responders, or those seeking wellness beyond fat loss
10.1038/ijo.2011.158 8 AstrupA.RossnerS.Van GaalL.RissanenA.NiskanenL.Al HakimM.et al
The medication is typically prescribed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m with weight-related comorbidities
This framework was used to clarify whether GLP-1RA-associated taste changes are better interpreted as alterations in gustatory function, hedonic food evaluation, cue-driven food motivation, or broader nutrition-related changes in food preference and dietary behaviour
Eleven percent had treated diabetes, 20% were on therapy for obstructive sleep apnea (OSAS), 30% were treated for hypertension, 11% had managed dyslipidemia, 23% reported arthralgia, and 22% had hepatopathy